<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Excessive daytime sleepiness due to medical disorders and medications</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Excessive daytime sleepiness due to medical disorders and medications</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Excessive daytime sleepiness due to medical disorders and medications</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Brian James Murray, MD, FRCPC D, ABSM</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Thomas E Scammell, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">April F Eichler, MD, MPH</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Nov 03, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1911891162"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Some patients have excessive daytime sleepiness (EDS) that is not caused by common disorders such as insufficient sleep, obstructive sleep apnea, or narcolepsy. This may manifest as excessive napping, inappropriate daytime sleep, or even accidents caused by falling asleep while driving or during other activities. In many cases, EDS is due to a treatable medical disorder, and proper diagnosis and treatment offers the possibility of improved daytime sleepiness along with improved medical outcomes.</p><p>This topic reviews medical and neurologic disorders associated with problematic sleepiness, beyond primary sleep disorders. An approach to the initial evaluation and management of a patient with EDS is presented separately. The evaluation and management of persistent sleepiness in patients with a known diagnosis of obstructive sleep apnea is also reviewed separately. (See  <a class="medical medical_review" href="/z/d/html/14892.html" rel="external">"Approach to the patient with excessive daytime sleepiness"</a> and  <a class="medical medical_review" href="/z/d/html/7687.html" rel="external">"Evaluation and management of residual excessive sleepiness in adults with obstructive sleep apnea"</a>.)</p><p class="headingAnchor" id="H1307275841"><span class="h1">DEFINITIONS</span><span class="headingEndMark"> — </span>Excessive daytime sleepiness (EDS) refers to the tendency to fall asleep in inappropriate settings. EDS is separate from mental and physical fatigue, which can be manifested as difficulty or inability initiating activity, reduced capacity maintaining activity, and/or difficulty with concentration and memory. Terms may be used interchangeably by patients, however, and it is not always possible to distinguish them by history alone.</p><p>In patients with sleep disorders, fatigue and sleepiness measures are correlated [<a href="#rid1">1</a>]. Clinically, fatigue may be worse after positional change or exercise, but EDS may be briefly improved. A patient with sleepiness may fall asleep when sedentary, but a patient with fatigue may not be able to initiate sleep when at rest.</p><p>In the author's experience, sleep disorders often contribute to sleepiness and may also contribute to fatigue. Therefore, efforts to identify and treat underlying sleep disorders are warranted as they may alleviate symptoms regardless of label [<a href="#rid2">2</a>]. (See  <a class="medical medical_review" href="/z/d/html/14892.html" rel="external">"Approach to the patient with excessive daytime sleepiness", section on 'Definitions'</a> and  <a class="medical medical_review" href="/z/d/html/2783.html" rel="external">"Approach to the adult patient with fatigue"</a>.)</p><p class="headingAnchor" id="H257185481"><span class="h1">INSUFFICIENT SLEEP</span><span class="headingEndMark"> — </span>Insufficient sleep is the most common and easily overlooked cause of excessive daytime sleepiness (EDS) [<a href="#rid3">3</a>]. In addition to a thorough history, a sleep log  (<a class="graphic graphic_table graphicRef87134" href="/z/d/graphic/87134.html" rel="external">table 1</a> and <a class="graphic graphic_table graphicRef87859" href="/z/d/graphic/87859.html" rel="external">table 2</a>) and actigraphy may help document the amount of sleep obtained and can identify factors contributing to poor sleep quality. High-risk groups include:</p><p class="bulletIndent1"><span class="glyph">●</span>Shift workers, who tend to progressively accumulate sleep loss over time (see  <a class="medical medical_review" href="/z/d/html/97846.html" rel="external">"Sleep-wake disturbances in shift workers"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Individuals with behaviorally induced sleep insufficiency due to working multiple jobs, poor sleep hygiene, and family obligations such as caring for children and older family members (see  <a class="medical medical_review" href="/z/d/html/7715.html" rel="external">"Insufficient sleep: Definition, epidemiology, and adverse outcomes"</a> and  <a class="medical medical_review" href="/z/d/html/97866.html" rel="external">"Insufficient sleep: Evaluation and management"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with chronic pain (see  <a class="medical medical_review" href="/z/d/html/116196.html" rel="external">"Evaluation of chronic non-cancer pain in adults", section on 'Pain severity and impact'</a> and  <a class="medical medical_review" href="/z/d/html/126633.html" rel="external">"Pharmacologic management of chronic non-cancer pain in adults"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hospitalized patients (see  <a class="medical medical_review" href="/z/d/html/97849.html" rel="external">"Poor sleep and insomnia in hospitalized adults"</a> and  <a class="medical medical_review" href="/z/d/html/106476.html" rel="external">"Obstructive sleep apnea and other sleep disorders in hospitalized adults"</a>)</p><p></p><p>The adverse effects, evaluation, and management of insufficient sleep are reviewed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/7715.html" rel="external">"Insufficient sleep: Definition, epidemiology, and adverse outcomes"</a> and  <a class="medical medical_review" href="/z/d/html/97866.html" rel="external">"Insufficient sleep: Evaluation and management"</a>.)</p><p class="headingAnchor" id="H667836989"><span class="h1">NEUROLOGIC DISORDERS</span><span class="headingEndMark"> — </span>The brain actively generates alertness and sleep, and a variety of neurologic disorders can cause excessive daytime sleepiness (EDS).</p><p class="headingAnchor" id="H1244451143"><span class="h2">Focal central nervous system lesions</span><span class="headingEndMark"> — </span>Alertness can be impaired by bilateral cortical lesions or midline lesions that damage wake-promoting brainstem regions or their ascending projections to the forebrain. Neuroimaging is unnecessary in most patients with sleepiness, but it should be considered in those with new or unexplained focal neurologic deficits on examination.</p><p class="bulletIndent1"><span class="glyph">●</span>Stroke – Sleepiness and fatigue are common after stroke and may be associated with poor outcomes [<a href="#rid4">4</a>]. One important secondary cause is sleep apnea, which is identified in approximately 60 percent of stroke survivors [<a href="#rid5">5</a>]. Clinical features and questionnaires, such as the Epworth Sleepiness Scale (ESS), lack sensitivity in patients with stroke, and diagnosis requires formal sleep testing with in-laboratory polysomnography or home sleep apnea testing. Treatment of obstructive sleep apnea has the potential to improve stroke rehabilitation outcomes as well as aid in secondary prevention [<a href="#rid6">6</a>]. (See  <a class="medical medical_review" href="/z/d/html/7716.html" rel="external">"Sleep-related breathing disorders and stroke"</a>.)</p><p></p><p class="bulletIndent1">EDS is occasionally a direct result of stroke. In such cases, symptoms are typically acute in onset and accompanied by focal neurologic signs. Side effects from medications are another potential cause of sleepiness after acute stroke. Sedating medications have been associated with poor stroke recovery and should be avoided if possible in this setting [<a href="#rid7">7</a>]. (See  <a class="medical medical_review" href="/z/d/html/1083.html" rel="external">"Overview of the evaluation of stroke"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Tumors – Tumors that damage the hypothalamus or midbrain can cause EDS directly by damaging wake-promoting systems or indirectly via secondary hydrocephalus and increased intracranial pressure, which effectively produces bilateral dysfunction of the cortex or midline structures. Tumors in these regions often produce abnormal eye movements, hemiparesis, or pituitary dysfunction, and nearly all of these lesions increase the total daily amount of sleep. Morning headaches can occur with brain tumors, although this pattern is nonspecific and can also be seen with other more common causes of sleepiness, such as obstructive sleep apnea. (See  <a class="medical medical_review" href="/z/d/html/5180.html" rel="external">"Overview of the clinical features and diagnosis of brain tumors in adults"</a> and  <a class="medical medical_review" href="/z/d/html/7706.html" rel="external">"Clinical presentation and diagnosis of obstructive sleep apnea in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Traumatic brain injury – EDS is a prominent symptom after traumatic brain injury, reported by 50 to 80 percent of patients [<a href="#rid8">8-11</a>]. Traumatic brain injury can acutely reduce orexin (hypocretin) levels in the spinal fluid, though levels usually recover later. Severe traumatic brain injury can also injure hypothalamic neurons that produce histamine, a key wake-promoting neurotransmitter. (See  <a class="medical medical_review" href="/z/d/html/96439.html" rel="external">"Sleep-wake disorders in patients with traumatic brain injury", section on 'Symptom spectrum'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Multiple sclerosis – Midline structures containing the projecting aminergic and cholinergic systems are particularly vulnerable to damage in patients with multiple sclerosis, and demyelination in these areas as well as inflammation more generally may result in EDS. Antibodies to aquaporin-4 and acute disseminated encephalomyelitis may produce sleepiness through a similar mechanism.</p><p></p><p class="bulletIndent1">Patients with multiple sclerosis are also at increased risk for a variety of sleep disorders, including restless legs syndrome (RLS) and obstructive sleep apnea, which may contribute to sleepiness. Side effects from medications are another important consideration. One study of 190 patients with multiple sclerosis found that 47 percent used a sedative hypnotic agent, which could have been contributing to fatigue [<a href="#rid12">12</a>]. (See  <a class="medical medical_review" href="/z/d/html/1689.html" rel="external">"Manifestations of multiple sclerosis in adults", section on 'Sleep disorders'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Neurosarcoidosis – Sarcoidosis has a predilection for the base of brain and hypothalamus in particular, and involvement of these structures may result in profound sleepiness [<a href="#rid13">13</a>]. Patients with neurologic sarcoidosis usually, but not always, have evidence of systemic disease on chest radiography or computed tomography. Magnetic resonance imaging (MRI) of the brain with gadolinium most commonly demonstrates meningeal and/or parenchymal enhancement in affected areas. (See  <a class="medical medical_review" href="/z/d/html/4834.html" rel="external">"Neurologic sarcoidosis"</a>.)</p><p></p><p class="headingAnchor" id="H878898020"><span class="h2">Epilepsy</span><span class="headingEndMark"> — </span>Epilepsy and sleep are highly interrelated. Sleep deprivation or poor sleep quality can precipitate seizures, whereas poor seizure control can disrupt sleep and lead to EDS [<a href="#rid14">14</a>]. One study of 100 patients with epilepsy noted that patients with nocturnal seizure patterns tended to have more daytime sleepiness [<a href="#rid15">15</a>]. Patients with poorly controlled epilepsy are also more likely to be on a variety of antiseizure drugs, many of which induce sleepiness from direct central nervous system effects or indirectly by inducing sleep apnea via relaxation of the upper airway [<a href="#rid16">16</a>]. (See  <a class="medical medical_review" href="/z/d/html/114559.html" rel="external">"Comorbidities and complications of epilepsy in adults", section on 'Sleep disorders'</a>.)</p><p class="headingAnchor" id="H3173893491"><span class="h2">Neurodegenerative disorders</span><span class="headingEndMark"> — </span>A variety of neurodegenerative conditions can induce sleepiness, depending on brain circuitry involved and stage of the disease.</p><p class="bulletIndent1"><span class="glyph">●</span>Parkinson disease is commonly associated with EDS, which may be profound and comparable to that of narcolepsy [<a href="#rid17">17</a>]. The EDS in early Parkinson disease progresses over time [<a href="#rid18">18</a>]. Pathologic studies have demonstrated some loss of the orexin-producing neurons in advanced stages of the disease, although this is probably not the main cause of EDS [<a href="#rid19">19</a>]. Management strategies, including bright light therapy, exercise, and pharmacologic treatments, are reviewed separately. (See  <a class="medical medical_review" href="/z/d/html/133139.html" rel="external">"Evaluation and treatment of insomnia, daytime sleepiness, and other sleep disorders in Parkinson disease", section on 'Excessive daytime sleepiness'</a>.)</p><p></p><p class="bulletIndent1">Other potential causes of sleepiness in patients with Parkinson disease include side effects of medications, disrupted sleep due to poorly controlled rigidity or pain, and comorbid sleep disorders, including sleep-related breathing disorders and periodic limb movements of sleep. (See  <a class="medical medical_review" href="/z/d/html/133139.html" rel="external">"Evaluation and treatment of insomnia, daytime sleepiness, and other sleep disorders in Parkinson disease", section on 'Insomnia'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Multiple system atrophy is associated with a similar degree of sleepiness as Parkinson disease. In one study, EDS was reported by 28 percent of patients with multiple system atrophy and correlated with the presence of self-reported sleep-disordered breathing [<a href="#rid20">20</a>]. (See  <a class="medical medical_review" href="/z/d/html/4890.html" rel="external">"Multiple system atrophy: Clinical features and diagnosis", section on 'Sleep and breathing disorders'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Dementia with Lewy bodies is associated with EDS as well as rapid eye movement (REM) sleep behavior disorder [<a href="#rid21">21</a>]. (See  <a class="medical medical_review" href="/z/d/html/5088.html" rel="external">"Clinical features and diagnosis of dementia with Lewy bodies", section on 'REM sleep behavior disorder'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Alzheimer disease can be associated with circadian rhythm disruption and sleepiness, particularly when there are Parkinsonian features [<a href="#rid22">22</a>]. (See  <a class="medical medical_review" href="/z/d/html/97863.html" rel="external">"Sleep-wake disturbances and sleep disorders in patients with dementia", section on 'Excessive daytime sleepiness'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Spinocerebellar ataxia may be associated with profound fatigue and EDS in approximately two-thirds of patients [<a href="#rid23">23</a>]. Patients with spinocerebellar ataxia type 3 (Machado-Joseph disease), the most common of the autosomal-dominant ataxias, also have an increased prevalence of REM sleep behavior disorder, RLS, and insomnia [<a href="#rid24">24,25</a>]. (See  <a class="medical medical_review" href="/z/d/html/6230.html" rel="external">"Autosomal dominant spinocerebellar ataxias", section on 'SCA3 (Machado-Joseph disease)'</a>.)</p><p></p><p class="headingAnchor" id="H320019873"><span class="h2">Encephalitis and postinfectious syndromes</span><span class="headingEndMark"> — </span>Brain inflammation can directly induce sleepiness, which may be mediated by cytokines. Autoimmune or postinfectious central nervous system syndromes can also cause sleepiness, in some cases due to hypothalamic involvement.</p><p class="bulletIndent1"><span class="glyph">●</span>Viral encephalitis can produce severe and diffuse cortical and subcortical injury, thereby causing sleepiness. Encephalitis lethargica, which was associated with profound EDS, may have had a viral etiology. (See  <a class="medical medical_review" href="/z/d/html/1284.html" rel="external">"Viral encephalitis in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>COVID-19 is associated with excessive daytime sleepiness in approximately one-third of patients in both the acute and chronic phases [<a href="#rid26">26,27</a>]. (See  <a class="medical medical_review" href="/z/d/html/128323.html" rel="external">"COVID-19: Clinical features"</a> and  <a class="medical medical_review" href="/z/d/html/129312.html" rel="external">"COVID-19: Evaluation and management of adults with persistent symptoms following acute illness ("Long COVID")"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Human African trypanosomiasis, or sleepiness sickness, is notable for profound insomnia and increased daytime sleep during the central nervous system phase of protozoal reproduction [<a href="#rid28">28</a>]. Despite increased daytime sleep, total sleep time in 24 hours may not be increased, and such sleep dysregulation reflects a circadian rhythm abnormality [<a href="#rid29">29</a>]. Fever, joint pain, and enlarged lymph nodes typically precede sleep dysregulation. (See  <a class="medical medical_review" href="/z/d/html/5697.html" rel="external">"Human African trypanosomiasis: Epidemiology, clinical manifestations, and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Postinfectious syndromes associated with pathologic sleepiness may include postinfluenza narcolepsy, which was noted to occur with increased frequency after the H1N1 influenza pandemic in Beijing in 2009 to 2010 and possibly to a lesser degree after H1N1 vaccination in certain countries [<a href="#rid30">30,31</a>]. There is a molecular homology between the orexin system and human leukocyte antigen (HLA)-presented influenza that has been hypothesized to be an autoimmune explanation for postinfluenza narcolepsy [<a href="#rid32">32</a>]. (See  <a class="medical medical_review" href="/z/d/html/7689.html" rel="external">"Clinical features and diagnosis of narcolepsy in adults", section on 'Autoimmune hypothesis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Paraneoplastic limbic encephalitis due to autoantibodies such as anti-Ma2, and anti-Hu is sometimes associated with EDS [<a href="#rid33">33</a>]. In one case series of six patients with anti-Ma2 encephalitis, low cerebrospinal fluid orexin levels were present in four patients with severe sleepiness [<a href="#rid34">34</a>]. Anti-IgLON5 disease is associated with multiple sleep problems, including parasomnias, sleep apnea, insomnia, and EDS, in the context of bulbar complications and movement disorders [<a href="#rid33">33</a>]. (See  <a class="medical medical_review" href="/z/d/html/15759.html" rel="external">"Autoimmune (including paraneoplastic) encephalitis: Clinical features and diagnosis"</a>.) </p><p></p><p class="headingAnchor" id="H3073834693"><span class="h2">Neuromuscular disorders</span><span class="headingEndMark"> — </span>A number of neuromuscular disorders are associated with EDS, independent of sleep-related breathing disorders, which occur with increased frequency in many neuromuscular disorders. Examples include the following:</p><p class="bulletIndent1"><span class="glyph">●</span>Myotonic dystrophy – EDS is a prominent clinical feature of myotonic dystrophy that may persist despite treatment of underlying central and obstructive sleep apnea [<a href="#rid35">35</a>]. Patients with myotonic dystrophy type 1 also can have sleep-onset REM periods, as seen in patients with narcolepsy [<a href="#rid36">36</a>]. <a class="drug drug_general" data-topicid="10157" href="/z/d/drug information/10157.html" rel="external">Modafinil</a> has been used with some success. (See  <a class="medical medical_review" href="/z/d/html/5147.html" rel="external">"Myotonic dystrophy: Etiology, clinical features, and diagnosis", section on 'Sleep disturbance'</a> and  <a class="medical medical_review" href="/z/d/html/5140.html" rel="external">"Myotonic dystrophy: Treatment and prognosis", section on 'Excessive daytime sleepiness'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Myasthenia gravis – Myasthenia gravis can be associated with daytime sleepiness, likely through an association with sleep-disordered breathing. In one pilot study, napping led to a 13 percent increase in motor function on a standardized scale, suggesting that sleep may provide therapeutic benefit [<a href="#rid37">37</a>]. (See  <a class="medical medical_review" href="/z/d/html/5170.html" rel="external">"Clinical manifestations of myasthenia gravis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Amyotrophic lateral sclerosis (ALS) – Patients with ALS are sleepy for a variety of reasons. Sleep difficulty is often secondary to other problems associated with ALS (eg, dyspnea, dysphagia, mood disorders, inability to change posture during sleep due to weakness). Patients are also at increased risk for sleep-disordered breathing and periodic limb movements of sleep. In a study that included 121 patients with ALS, the prevalence of sleepiness was 26 percent, and ESS scores correlated with global ALS severity scores [<a href="#rid38">38</a>]. (See  <a class="medical medical_review" href="/z/d/html/5129.html" rel="external">"Symptom-based management of amyotrophic lateral sclerosis", section on 'Respiratory function management'</a> and  <a class="medical medical_review" href="/z/d/html/5129.html" rel="external">"Symptom-based management of amyotrophic lateral sclerosis", section on 'Sleep problems'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Facioscapulohumeral dystrophy (FSHD) – FSHD can cause respiratory complications, and sleep may also be disrupted by pain. In a study of 690 individuals with FSHD, 15 percent had sleepiness defined as an ESS score &gt;10 [<a href="#rid39">39</a>]. (See  <a class="medical medical_review" href="/z/d/html/87096.html" rel="external">"Facioscapulohumeral muscular dystrophy", section on 'Clinical features'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hereditary sensory and autonomic neuropathy type 1E – Patients with sensory and autonomic neuropathy type 1E, caused by mutations in DNMT1, have an increased incidence of a range of sleep disorders, including narcolepsy and REM sleep behavior disorder [<a href="#rid40">40</a>]. (See  <a class="medical medical_review" href="/z/d/html/6227.html" rel="external">"Hereditary sensory and autonomic neuropathies", section on 'HSAN1'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Postural tachycardia syndrome – In one study, patients with postural tachycardia syndrome had increased daytime sleepiness compared with controls as assessed by the ESS [<a href="#rid41">41</a>]. (See  <a class="medical medical_review" href="/z/d/html/5100.html" rel="external">"Postural tachycardia syndrome"</a>.)</p><p></p><p class="headingAnchor" id="H620890697"><span class="h2">Headache</span><span class="headingEndMark"> — </span>Migraine sufferers may have an increased prevalence of EDS, even when free of headache [<a href="#rid42">42</a>]. In a population-based study, the rate of EDS was approximately twofold higher in patients with migraine compared with non-headache controls (20 versus 9 percent) [<a href="#rid43">43</a>]. This is of particular interest, as many patients with migraine desire sleep to ameliorate symptoms.</p><p>Frequent yawning is seen during migraine and can also a harbinger of an impending headache [<a href="#rid44">44</a>]. Migraineurs with night-time attacks may represent a subset of patients with more severe and disabling migraine [<a href="#rid45">45</a>]. Basilar migraine can cause sleepiness and even loss of consciousness, possibly through dysfunction of brainstem wake-promoting systems. Some of the chronic prophylactic agents for migraine therapy can also contribute to sleepiness.</p><p>Other headache types are similarly associated with daytime sleepiness. One study of 93 patients with secondary headaches of various types found 23 percent had EDS [<a href="#rid46">46</a>].</p><p class="headingAnchor" id="H2017802784"><span class="h2">Neurogenetic disorders</span><span class="headingEndMark"> — </span>Although neurogenetic disorders are rare when considered individually, collectively they may represent a significant medical cause of EDS. Often these conditions will present in childhood and have associated systemic abnormalities. Examples of disorders associated with sleepiness include:</p><p class="bulletIndent1"><span class="glyph">●</span>Prader-Willi syndrome – Approximately two-thirds of adults with Prader-Willi syndrome report EDS, sometimes with cataplexy-like symptoms [<a href="#rid47">47,48</a>]. Narcolepsy type 1 with classic clinical features and low cerebrospinal fluid orexin levels occurs but is relatively uncommon [<a href="#rid48">48,49</a>]; more commonly, patients have idiopathic hypersomnia, narcolepsy type 2 (narcolepsy without cataplexy), or a mixed hypersomnia phenotype [<a href="#rid48">48</a>]. Obesity is often comorbid, and patients are also at high risk for sleep-related breathing disorders. However, EDS often persists despite adequate treatment of sleep apnea. Some patients may respond to symptomatic treatment with <a class="drug drug_general" data-topicid="10157" href="/z/d/drug information/10157.html" rel="external">modafinil</a> [<a href="#rid48">48</a>]. (See  <a class="medical medical_review" href="/z/d/html/5864.html" rel="external">"Prader-Willi syndrome: Management", section on 'Sleep and respiratory disorders'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Niemann-Pick type C – EDS with or without cataplexy can be seen in patients with Niemann-Pick type C, in association with additional neurologic symptoms (eg, movement disorders, dementia, and eye movement abnormalities) and hepatosplenomegaly. The age of onset and clinical presentation of Niemann-Pick type C are highly variable, and rare patients present in adulthood. Low hypocretin levels in some patients suggest that lysosomal storage abnormalities in the hypothalamus may contribute to the pathogenesis of sleepiness [<a href="#rid50">50</a>]. (See  <a class="medical medical_review" href="/z/d/html/6196.html" rel="external">"Overview of Niemann-Pick disease"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Moebius syndrome – Moebius syndrome is characterized by congenital facial diplegia and bilateral abducens palsies. Sleepiness in these patients may be related to underlying migrational abnormalities in the brainstem that may affect arousal-promoting pathways. (See  <a class="medical medical_review" href="/z/d/html/6217.html" rel="external">"Facial nerve palsy in children", section on 'Congenital facial nerve palsy'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Fragile X syndrome – Fragile X syndrome is an X-linked disorder caused by loss-of-function mutations in the fragile X messenger ribonucleoprotein 1 (<em>FMR1</em>) gene. It is the most common inherited cause of intellectual disability and is often also associated with behavioral abnormalities, including autism spectrum disorder and attentional difficulties [<a href="#rid51">51</a>]. Although X-linked, both males and females can be affected. Dysmorphic features may be present, along with tremor or cerebellar abnormalities. (See  <a class="medical medical_review" href="/z/d/html/2924.html" rel="external">"Fragile X syndrome: Clinical features and diagnosis in children and adolescents"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Williams syndrome – About one-third of patients with Williams syndrome, also known as Williams-Beuren syndrome, have EDS despite adequate sleep time [<a href="#rid52">52</a>]. Increased sleep fragmentation and movements during sleep have been noted using actigraphy, but this has not yet been explored by polysomnography. Williams syndrome is a multisystem disorder caused by hemizygous deletion of a portion of chromosome 7q, typically recognized by facial dysmorphism ("elfin" facies) and overly friendly personality. (See  <a class="medical medical_review" href="/z/d/html/16660.html" rel="external">"Microdeletion syndromes (chromosomes 1 to 11)", section on '7q11.23 deletion syndrome (Williams syndrome)'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Smith-Magenis syndrome – Smith-Magenis syndrome (17p11.2 deletion syndrome) is a condition with facial dysmorphism and high impulsivity that is often associated with significant sleep problems and daytime sleepiness [<a href="#rid53">53</a>]. (See  <a class="medical medical_review" href="/z/d/html/16648.html" rel="external">"Microdeletion syndromes (chromosomes 12 to 22)", section on '17p11.2 deletion syndrome (Smith-Magenis syndrome)'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cyclin-dependent kinase-like 5 deficiency disorder – Cyclin-dependent kinase-like 5 deficiency disorder is associated with developmental delay and severe epilepsy. A study of 129 children with this disorder noted that excessive daytime sleepiness was of particular concern to families and had an impact on quality of life [<a href="#rid54">54</a>]. Seizures, sleep disruption, and medication effects may all contribute to somnolence.</p><p></p><p class="headingAnchor" id="H3991184751"><span class="h1">MEDICAL CONDITIONS</span></p><p class="headingAnchor" id="H2821056376"><span class="h2">Cardiovascular disease</span><span class="headingEndMark"> — </span>A variety of cardiovascular diseases are associated with excessive daytime sleepiness (EDS), often related to comorbid sleep-related breathing disorders. Obstructive sleep apnea is an important consideration, particularly in patients with obesity or metabolic syndrome. Heart failure is associated with an increased prevalence of central sleep apnea and Cheyne-Stokes respiration. (See  <a class="medical medical_review" href="/z/d/html/7705.html" rel="external">"Obstructive sleep apnea and cardiovascular disease in adults"</a> and  <a class="medical medical_review" href="/z/d/html/7682.html" rel="external">"Sleep-disordered breathing in heart failure"</a>.)</p><p class="headingAnchor" id="H881599159"><span class="h2">Respiratory conditions</span><span class="headingEndMark"> — </span>Chronic obstructive pulmonary disease may be associated with profound oxygen desaturation despite minimal respiratory events on a polysomnogram. Associated hypoxia and hypercapnia may contribute to cerebral injury and hypersomnolence [<a href="#rid55">55</a>]. Along with EDS, patients may have morning headaches associated with hypercarbia-induced vasodilation, as well as asterixis and myoclonus.</p><p>Other potential causes of EDS in patients with respiratory disease include chronic cough, which may fragment nocturnal sleep, and systemic inflammation.</p><p class="headingAnchor" id="H1644616685"><span class="h2">Systemic inflammation</span><span class="headingEndMark"> — </span>Inflammatory cytokines (eg, interleukin-1-beta, interleukin-6, tumor necrosis factor alpha) and prostaglandins are well-known sleep-promoting factors [<a href="#rid56">56,57</a>]. Any chronic infection or inflammatory condition may result in sleepiness, possibly due to these inflammatory mediators. Some of the more common examples are rheumatologic disease and cancer.</p><p class="bulletIndent1"><span class="glyph">●</span>Rheumatologic disorders – Fatigue and EDS related to profound inflammation are prominent symptoms in many patients with rheumatologic disorders. Joint pain and reduced physical activity may also contribute to sleep disruption and subsequent EDS, although in some cases active pain may increase arousal and counteract daytime sleepiness [<a href="#rid58">58</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Malignancy – EDS is commonly seen in patients with malignancy [<a href="#rid59">59,60</a>]. Contributing factors may include the direct effects of cytokines produced in response to the cancer, cytokine release associated with tumor lysis syndrome, side effects from chemotherapy or radiation, and the presence of metastatic disease in the brain [<a href="#rid61">61,62</a>]. In a study of 16 patients with malignancy who underwent a multiple sleep latency test, the mean sleep latency was less than eight minutes in 69 percent [<a href="#rid63">63</a>].</p><p></p><p class="headingAnchor" id="H3045934994"><span class="h2">Hematologic disorders</span><span class="headingEndMark"> — </span>Hematologic disorders can produce sleepiness by way of associated sleep disorders.</p><p class="bulletIndent1"><span class="glyph">●</span>Iron deficiency – Iron deficiency is often associated with restless legs syndrome (RLS) and periodic limb movements of sleep, which may interfere with sleep and result in EDS. A study of 744 older adult patients noted excessive daytime sleepiness defined by an Epworth Sleepiness Scale (ESS) score &gt;10 in 24 percent [<a href="#rid64">64</a>]. Reductions in gray matter iron stores [<a href="#rid65">65</a>] may also contribute directly to a reduction in projecting alertness system function. Cerebral iron stores may be considerably lower than what is detected by peripheral blood measures, and even patients with a "low normal" ferritin (eg, ≤75 to 100 ng/mL) may improve with iron supplementation. Comorbid depression is also important to recognize and treat, as mood symptoms may be interpreted as sleepiness. (See  <a class="medical medical_review" href="/z/d/html/4892.html" rel="external">"Clinical features and diagnosis of restless legs syndrome and periodic limb movement disorder in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hemochromatosis – Patients with hemochromatosis may have EDS related to iron overload and subsequent hepatic dysfunction (see <a class="local">'Metabolic encephalopathy'</a> below). Endocrine dysfunction as a result of iron deposition in the pituitary is another potential cause of sleepiness. (See  <a class="medical medical_review" href="/z/d/html/7167.html" rel="external">"Clinical manifestations and diagnosis of hereditary hemochromatosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Sickle cell disease – Obstructive sleep apnea and other forms of sleep-disordered breathing occur with increased frequency in patients with sickle cell disease [<a href="#rid66">66</a>]. In addition to producing EDS, sleep apnea may also increase the frequency of acute pain episodes and chronic cardiopulmonary disease. (See  <a class="medical medical_review" href="/z/d/html/7121.html" rel="external">"Overview of the pulmonary complications of sickle cell disease", section on 'Sleep-disordered breathing'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Primary immune thrombocytopenia – In a study of 653 patients with primary immune thrombocytopenia, fatigue and/or sleepiness were reported by 20 to 40 percent of patients and correlated with low platelet count, treatment with steroids, bleeding symptoms, and the presence of other comorbid conditions [<a href="#rid67">67</a>]. (See  <a class="medical medical_review" href="/z/d/html/6676.html" rel="external">"Immune thrombocytopenia (ITP) in adults: Clinical manifestations and diagnosis"</a>.)</p><p></p><p class="headingAnchor" id="H3315200994"><span class="h2">Metabolic encephalopathy</span><span class="headingEndMark"> — </span>Metabolic abnormalities due to organ dysfunction can result in sleepiness ranging from mild symptoms to profound encephalopathy with obtundation and coma.</p><p class="bulletIndent1"><span class="glyph">●</span>Hepatic dysfunction – Sleep-wake disturbances, including both insomnia and EDS, are common initial manifestations of hepatic encephalopathy that may precede other neurologic symptoms and signs in patients with liver dysfunction and/or portosystemic shunting. In patients with more severe sleepiness, attentional difficulties, psychomotor slowing, and associated movement disorders such as asterixis will often be present. Most patients with hepatic encephalopathy have advanced chronic liver disease and physical stigmata of hepatic dysfunction. (See  <a class="medical medical_review" href="/z/d/html/1237.html" rel="external">"Hepatic encephalopathy in adults: Clinical manifestations and diagnosis"</a>.)</p><p></p><p class="bulletIndent1">Chronic liver disease can also be associated with EDS, even in the absence of hepatic encephalopathy. In a study of 48 women with primary biliary cirrhosis and normal liver synthetic function, more than half of patients had significant daytime sleepiness (ESS score &gt;10) [<a href="#rid68">68</a>]. Compared with healthy controls, these patients also had twice as much daytime sleep as measured by actigraphy [<a href="#rid68">68</a>]. A study of 192 patients with metabolic dysfunction-associated steatotic liver disease noted that an ESS score &gt;10 was a predictor of reduced health-related quality of life in a diverse population [<a href="#rid69">69</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Renal failure – EDS is common in patients with renal failure and may arise from multiple factors. Patients with end-stage renal disease are at increased risk for sleep apnea, which can be worsened by fluid overload [<a href="#rid70">70</a>]. RLS and periodic limb movements affect up to 50 percent of patients on hemodialysis. Other potential contributing factors include insomnia, poor sleep quality, and side effects from medications. Elevated metabolites may also play a role [<a href="#rid71">71</a>]. (See  <a class="medical medical_review" href="/z/d/html/16197.html" rel="external">"Sleep disorders in end-stage kidney disease"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Endocrine disorders – A variety of endocrine disorders, including diabetes, clinical and subclinical hypothyroidism, pituitary adenomas, and Addison's disease, can be associated with EDS [<a href="#rid72">72,73</a>]. In patients with diabetes, episodes of severe hypoglycemia may increase the likelihood of daytime sleepiness [<a href="#rid74">74</a>]. Polycystic ovarian syndrome is also associated with EDS as well as an increased incidence of sleep-disordered breathing [<a href="#rid75">75</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Toxin exposure – Industrial toxins or organic solvents such as cyclohexane [<a href="#rid76">76</a>] can be associated with encephalopathy as well as sleep disruption and sleepiness [<a href="#rid77">77</a>]. Organic solvents in particular can damage white matter tracts, possibly including those that contribute to ascending wakefulness drive. An occupational history may help identify exposure to these agents.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Rare metabolic disorders – Rare metabolic disorders should be considered as a cause of otherwise unexplained EDS, especially in children and when there is a family history. Ornithine transcarbamylase deficiency and mitochondrial disorders may be associated with intermittent encephalopathy with sleepiness as well as intermittent symptoms in multiple organ systems. Hearing loss and short stature are classic clues for a mitochondrial abnormality, and a maternal inheritance pattern may be identified. Screening can be initiated with lactate and pyruvate levels as well as amino acid levels and urine organic acid profiles in selected patients. (See  <a class="medical medical_review" href="/z/d/html/17216.html" rel="external">"Inborn errors of metabolism: Identifying the specific disorder"</a>.)</p><p></p><p class="headingAnchor" id="H724492935"><span class="h2">Peptic ulcer disease and reflux</span><span class="headingEndMark"> — </span>In a study of over 2500 adults with a range of medical disorders and no suspicion for sleep apnea or narcolepsy, peptic ulcer disease was the most common medical disorder associated with sleepiness, with 50 percent of patients reporting significant daytime sleepiness [<a href="#rid42">42</a>].</p><p>Gastroesophageal reflux can cause arousals from sleep that may not be evident on routine polysomnography that does not include esophageal pH measurements [<a href="#rid78">78</a>]. In patients with daytime reflux symptoms and sleepiness that is otherwise unexplained, dietary manipulation, sleeping in the left lateral decubitus position with the head of the bed slightly raised, and a trial of an acid-reducing agent may help clarify the diagnosis.</p><p class="headingAnchor" id="H4139507966"><span class="h2">Vitamin deficiencies</span><span class="headingEndMark"> — </span>In severe cases, vitamin B12 deficiency can be associated with white matter lesions and subsequent EDS. Precipitation of severe symptoms in previously borderline B12 deficiency has been noted with exposure to <a class="drug drug_general" data-topicid="10086" href="/z/d/drug information/10086.html" rel="external">nitrous oxide</a>. Limited data suggest that vitamin B12 also has effects on circadian rhythms, including one study demonstrating enhanced vigilance after adding B12 to circadian phototherapy in 28 patients with Alzheimer disease [<a href="#rid79">79</a>].</p><p>Vitamin D deficiency occurs with increased frequency in multiple sclerosis and sleep apnea [<a href="#rid80">80</a>]. Whether vitamin D deficiency is implicated in EDS is unclear, and the relationship may be confounded by reduced light exposure and physical activity.</p><p class="headingAnchor" id="H618885975"><span class="h2">Pregnancy</span><span class="headingEndMark"> — </span>Pregnant women are nearly twice as likely as controls to report EDS [<a href="#rid81">81</a>]. Sleep is often disrupted during pregnancy, with multiple contributors including hormonal changes, back pain and other physical discomforts, sleep-disordered breathing [<a href="#rid82">82</a>], and RLS. Sleep disruption may persist postpartum, independent of care of the newborn. (See  <a class="medical medical_review" href="/z/d/html/14202.html" rel="external">"Obstructive sleep apnea in pregnancy"</a> and  <a class="medical medical_review" href="/z/d/html/98366.html" rel="external">"Restless legs syndrome during pregnancy and lactation"</a>.)</p><p class="headingAnchor" id="H1314068458"><span class="h1">MEDICATIONS</span><span class="headingEndMark"> — </span>A variety of medications and substances can cause sleepiness directly or indirectly through aggravation of sleep disorders. In general, medications that cause sleepiness should be given at night, when possible, to minimize daytime effects.</p><p class="headingAnchor" id="H2613692050"><span class="h2">Sleep aids and opioids</span><span class="headingEndMark"> — </span>Sleep aids are widely prescribed and may be unnecessary in many patients. Daytime sleepiness in patients taking sleep aids can often be addressed by reducing or eliminating sedative agents, focusing on behavioral therapies, and effectively treating any underlying sleep disorders or medical conditions.</p><p class="bulletIndent1"><span class="glyph">●</span>Benzodiazepines and nonbenzodiazepine benzodiazepine receptor agonists ("Z-drug" hypnotics) induce sleepiness by enhancing gamma-aminobutyric acid (GABA)-ergic signaling. As with all drugs, the possibility of bioaccumulation due to reduced metabolism or elimination in the setting of hepatic dysfunction should be considered, particularly in older adults and women. (See  <a class="medical medical_review" href="/z/d/html/97868.html" rel="external">"Pharmacotherapy for insomnia in adults", section on 'Benzodiazepine receptor agonists'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Barbiturates and opioids may suppress alertness as well as impair respiration in sleep. Combining of these drugs with other sedatives can produce dangerous synergistic effects. (See  <a class="medical medical_review" href="/z/d/html/97859.html" rel="external">"Sleep-disordered breathing in patients chronically using opioids", section on 'Effects of opioids on sleep and respiration'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Over-the-counter agents associated with sleepiness include antihistamines, which directly antagonize wake-promoting histamine signaling, and some natural health products, such as valerian, melatonin, and kava. Contamination by unknown harmful substances should also be considered as a cause of sleepiness in patients taking poorly regulated health products.</p><p></p><p class="headingAnchor" id="H822776650"><span class="h2">Medications used for neurologic and psychiatric disorders</span></p><p class="bulletIndent1"><span class="glyph">●</span>Many antiseizure drugs have direct sedating effects [<a href="#rid83">83</a>]. Serum drug levels may be useful to rule out excess drug accumulation when sleepiness is prominent. Serum ammonia should be checked in patients with excessive sleepiness on <a class="drug drug_general" data-topicid="10035" href="/z/d/drug information/10035.html" rel="external">valproic acid</a>, as toxicity can cause encephalopathy via hyperammonemia in the absence of other liver function abnormalities. <a class="drug drug_general" data-topicid="10109" href="/z/d/drug information/10109.html" rel="external">Carnitine supplementation</a> can reduce ammonia levels in this setting. (See  <a class="medical medical_review" href="/z/d/html/338.html" rel="external">"Valproic acid poisoning", section on 'Carnitine supplementation'</a>.)</p><p></p><p class="bulletIndent1">Some antiseizure drugs may relax airway muscles and precipitate obstructive sleep apnea or sleep-related breathing disorders, leading indirectly to daytime sleepiness. (See  <a class="medical medical_review" href="/z/d/html/114559.html" rel="external">"Comorbidities and complications of epilepsy in adults", section on 'Sleep disorders'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Antipsychotics are often sedating and can aggravate restless legs syndrome (RLS) and periodic limb movements of sleep. Among atypical antipsychotics, <a class="drug drug_general" data-topicid="9570" href="/z/d/drug information/9570.html" rel="external">quetiapine</a> may be the most likely to cause EDS [<a href="#rid84">84</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Anticholinergic agents are often prescribed for pain syndromes and can induce somnolence. Most tricyclic antidepressants have anticholinergic features.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Antidepressants can have alerting or sedative characteristics, depending on the specific drug and the individual [<a href="#rid85">85</a>]. Patients with daytime sleepiness may do best with an alerting antidepressant taken in the morning. (See  <a class="medical medical_review" href="/z/d/html/1725.html" rel="external">"Unipolar major depression in adults: Choosing initial treatment", section on 'Side effects'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Dopaminergic drugs and direct dopaminergic agonists are associated with hypersomnolence, particularly at higher doses and in patients with Parkinson disease [<a href="#rid86">86</a>].</p><p></p><p class="headingAnchor" id="H516898610"><span class="h2">Medications used for other conditions</span><span class="headingEndMark"> — </span>Many other common medications may produce sleepiness, especially in the setting of underlying organ dysfunction, multiple medical comorbidities, or advanced age.</p><p class="bulletIndent1"><span class="glyph">●</span>Nonsteroidal anti-inflammatory drugs such as <a class="drug drug_general" data-topicid="8907" href="/z/d/drug information/8907.html" rel="external">aspirin</a> and <a class="drug drug_general" data-topicid="8547" href="/z/d/drug information/8547.html" rel="external">ibuprofen</a> taken during the daytime can produce mild daytime sleepiness, possibly via interference with prostaglandin production [<a href="#rid87">87</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Antimicrobials such as penicillin and <a class="drug drug_general" data-topicid="9646" href="/z/d/drug information/9646.html" rel="external">metronidazole</a> may have direct central nervous system effects. A causal relationship can be difficult to determine in the context of illness and organ failure, which may also contribute to somnolence [<a href="#rid88">88</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Antispasmodics often have anticholinergic properties associated with sleepiness.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Antiarrhythmic agents can induce sleepiness. <a class="drug drug_general" data-topicid="9360" href="/z/d/drug information/9360.html" rel="external">Digoxin</a> in particular has a relatively narrow therapeutic window, and drug interactions and changes in renal function can increase serum levels and lead to toxicity. (See  <a class="medical medical_review" href="/z/d/html/1051.html" rel="external">"Treatment with digoxin: Initial dosing, monitoring, and dose modification"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Alpha-2 agonists such as <a class="drug drug_general" data-topicid="9285" href="/z/d/drug information/9285.html" rel="external">clonidine</a> and alpha-1 antagonists such as <a class="drug drug_general" data-topicid="9806" href="/z/d/drug information/9806.html" rel="external">prazosin</a> can be sedating.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Beta-blockers have been associated with sleep disruption and consequent daytime sleepiness as well as impairments in mood.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Diuretic medications may cause nocturia, thereby disrupting sleep and producing daytime sleepiness.</p><p></p><p class="headingAnchor" id="H453450919"><span class="h2">Substance abuse</span><span class="headingEndMark"> — </span>Toxicology screens for drugs of abuse should be considered in patients with unexplained sleepiness, particularly when symptoms are acute. Alcohol, marijuana, and opioids are some of the more common substances associated with excessive sleepiness.</p><p class="bulletIndent1"><span class="glyph">●</span>Alcohol, marijuana, and opioid intoxication syndromes are commonly associated with excessive sleepiness. Alcohol is acutely sedating, and chronic use can also produce daytime sleepiness by fragmenting sleep. Marijuana can produce abnormalities on the multiple sleep latency test (MSLT) that are compatible with narcolepsy [<a href="#rid89">89</a>]. Opioids can induce chronic daytime sleepiness [<a href="#rid90">90</a>], independent of their effects on breathing patterns and apneas during sleep. (See  <a class="medical medical_review" href="/z/d/html/97847.html" rel="external">"Insomnia in patients with a substance use disorder", section on 'Clinical features'</a> and  <a class="medical medical_review" href="/z/d/html/97859.html" rel="external">"Sleep-disordered breathing in patients chronically using opioids"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Gamma hydroxybutyrate (GHB) intoxication should be considered in cases of profound coma that resolves in several hours with no apparent abnormality on toxicology screen. GHB has a short half-life and is not detected on routine toxicology screens. Definitive confirmation requires gas chromatography/mass spectrometry analysis. (See  <a class="medical medical_review" href="/z/d/html/307.html" rel="external">"Gamma hydroxybutyrate (GHB) intoxication"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Withdrawal of stimulating substances may trigger hypersomnolence. Cocaine and amphetamine withdrawal can produce sleepiness and even sleep-onset rapid eye movement (REM) periods (SOREMPs) on an MSLT. <a class="drug drug_general" data-topicid="9213" href="/z/d/drug information/9213.html" rel="external">Caffeine</a> withdrawal may also be associated with sleepiness and headache. Many commonly used over-the-counter products contain significant amounts of caffeine, and this should be considered in a detailed medication and substance use history.</p><p></p><p class="headingAnchor" id="H3865534217"><span class="h1">EVALUATION AND MANAGEMENT</span><span class="headingEndMark"> — </span>There is no single effective treatment for sleepiness related to medical disorders. Efforts should be made to address the underlying medical disorder and maximize symptomatic management.</p><p>While most of the medical disorders reviewed above will be apparent by history, physical examination, and basic blood work (see  <a class="medical medical_review" href="/z/d/html/14892.html" rel="external">"Approach to the patient with excessive daytime sleepiness", section on 'Initial evaluation'</a>), additional tests may be warranted in selected patients. Examples include lactate and pyruvate for suspected mitochondrial disorders, serum ammonia to rule out hyperammonemia, endocrine testing, and an erythrocyte sedimentation rate. A history of restless legs or periodic limb movements during sleep should prompt measurement of serum ferritin, B12, and creatinine. Blood and urine toxicology screens should be considered when there are few clues to the source of symptoms or in the presence of drug-seeking behaviors. Magnetic resonance imaging (MRI) of the brain with contrast may be indicated when there are focal neurologic signs or suspicion for an inflammatory neurologic process. (See <a class="local">'Neurologic disorders'</a> above and <a class="local">'Medical conditions'</a> above and <a class="local">'Substance abuse'</a> above.)</p><p>Recognition and treatment of comorbid sleep and circadian rhythm disorders are paramount  (<a class="graphic graphic_table graphicRef86811" href="/z/d/graphic/86811.html" rel="external">table 3</a>). In particular, obstructive sleep apnea is common, frequently undiagnosed, and often inadequately treated due to poor adherence to positive airway pressure therapy. Polysomnography or home sleep apnea testing is required to make a diagnosis of sleep apnea and to confirm adequate response to therapy. The role of polysomnography, the multiple sleep latency test (MSLT), and other additional testing in the initial evaluation of sleepiness is reviewed separately. (See  <a class="medical medical_review" href="/z/d/html/14892.html" rel="external">"Approach to the patient with excessive daytime sleepiness", section on 'Testing'</a>.)</p><p>Ensuring adequate sleep time is essential for all patients with daytime sleepiness. In cases of uncertainty, actigraphy may be a useful adjunct to sleep logs to help quantify sleep and detect unrecognized circadian and sleep disorders. (See  <a class="medical medical_review" href="/z/d/html/97866.html" rel="external">"Insufficient sleep: Evaluation and management"</a>.)</p><p>Elimination of sedating medications is helpful if possible. Timing of medications can be adjusted to get maximal sedative effects at night. Stimulating medications should be taken in the daytime. (See <a class="local">'Medications'</a> above.)</p><p>Behavioral strategies include more light exposure in the daytime, which can improve alertness. Physical activity or even position changes (eg, standing instead of sitting) can also increase alertness during monotonous tasks or situations.</p><p>If sleepiness persists despite optimal treatment of the underlying medical disorder, then a wake-promoting medication can be considered [<a href="#rid91">91,92</a>]. There are no established pharmacologic therapies for symptomatic management of sleepiness in this setting. Wake-promoting agents (eg, <a class="drug drug_general" data-topicid="10157" href="/z/d/drug information/10157.html" rel="external">modafinil</a>, <a class="drug drug_general" data-topicid="9260" href="/z/d/drug information/9260.html" rel="external">armodafinil</a>) or stimulants (eg, <a class="drug drug_general" data-topicid="9638" href="/z/d/drug information/9638.html" rel="external">methylphenidate</a>) might be expected to have some benefit based on experience in patients with central disorders of hypersomnolence such as narcolepsy (see  <a class="medical medical_review" href="/z/d/html/7681.html" rel="external">"Treatment of narcolepsy in adults", section on 'Approach to pharmacotherapy'</a>), but direct data are very limited in patients with sleepiness due to a medical or neurologic disorder. Specific patient groups in which these drugs have been studied, sometimes with mixed results, include the following:</p><p class="bulletIndent1"><span class="glyph">●</span>Multiple sclerosis (see  <a class="medical medical_review" href="/z/d/html/1690.html" rel="external">"Symptom management of multiple sclerosis in adults", section on 'Fatigue'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Parkinson disease (see  <a class="medical medical_review" href="/z/d/html/133139.html" rel="external">"Evaluation and treatment of insomnia, daytime sleepiness, and other sleep disorders in Parkinson disease", section on 'Wake-promoting agents'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Traumatic brain injury (see  <a class="medical medical_review" href="/z/d/html/96439.html" rel="external">"Sleep-wake disorders in patients with traumatic brain injury", section on 'Excessive daytime sleepiness'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cancer-related fatigue (see  <a class="medical medical_review" href="/z/d/html/2813.html" rel="external">"Cancer-related fatigue: Treatment", section on 'Psychostimulants and other wakefulness agents'</a>)</p><p></p><p>In the author's experience, a trial of <a class="drug drug_general" data-topicid="10157" href="/z/d/drug information/10157.html" rel="external">modafinil</a> may be worthwhile in patients with persistent excessive daytime sleepiness, preferably confirmed objectively on an MSLT. Such objective physiologic measures are helpful to track medication response. Other sleep disorders should be ruled out and appropriate behavioral strategies implemented. Stimulant medications are typically reserved for more refractory symptoms. <a class="drug drug_general" data-topicid="122332" href="/z/d/drug information/122332.html" rel="external">Pitolisant</a> and <a class="drug drug_general" data-topicid="120816" href="/z/d/drug information/120816.html" rel="external">solriamfetol</a> may also be considered based on experience in sleep apnea as adjunctive therapy [<a href="#rid93">93,94</a>]. (See  <a class="medical medical_review" href="/z/d/html/7687.html" rel="external">"Evaluation and management of residual excessive sleepiness in adults with obstructive sleep apnea", section on 'Treatment'</a>.)</p><p>Potential side effects and cost often factor into decisions, and safety of certain medications may vary based on underlying organ dysfunction and concurrent medications such as <a class="drug drug_general" data-topicid="10050" href="/z/d/drug information/10050.html" rel="external">warfarin</a> or hormonal contraception, which might pose problems in terms of drug interactions. A typical starting dose of <a class="drug drug_general" data-topicid="10157" href="/z/d/drug information/10157.html" rel="external">modafinil</a> is 100 mg in the morning; a second dose of 100 mg at noon can be added if necessary. A reduced starting dose is advised in older adults.</p><p>Regardless of the underlying cause, patients with daytime sleepiness should be warned about the risks of drowsy driving and educated about prevention and risk modification. (See  <a class="medical medical_review" href="/z/d/html/101086.html" rel="external">"Drowsy driving: Risks, evaluation, and management", section on 'Prevention and countermeasures'</a>.)</p><p class="headingAnchor" id="H4000895140"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Insufficient sleep</strong> – Insufficient sleep is perhaps the most common and easily overlooked cause of excessive daytime sleepiness (EDS) in patients with medical illness. High-risk groups include shift workers, patients with competing family responsibilities, patients with chronic pain, and hospitalized patients. (See <a class="local">'Insufficient sleep'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Neurologic disorders</strong> – Neurologic disorders can manifest with EDS due to involvement of the cortex bilaterally or midline structures that are critical for maintaining alertness. Other neurologic disorders are associated with an increased risk of primary sleep disorders such as sleep apnea and periodic limb movement disorder. (See <a class="local">'Neurologic disorders'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Medical conditions</strong> – A wide range of chronic medical illnesses are associated with sleepiness, which may be mediated by inflammatory cytokines, endocrine dysfunction, metabolic encephalopathy, or comorbid sleep disorders. (See <a class="local">'Medical conditions'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Medication side effects</strong> – Side effects of medications are an important cause of EDS in patients with chronic illness. Such patients are often at increased risk for sedative side effects due to polypharmacy, organ dysfunction, and advanced age. (See <a class="local">'Medications'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Evaluation and management – </strong>There is no single effective treatment for EDS related to medical disorders, and management requires a stepwise approach. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Ensuring adequate sleep time is essential for all patients. Comorbid sleep disorders should be diagnosed and treated. In particular, obstructive sleep apnea is common, frequently undiagnosed, and often inadequately treated due to poor adherence to positive airway pressure therapy. Essential medications with sedative properties should be given at night, when possible, and alerting medications given in the morning. (See <a class="local">'Evaluation and management'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The role of wake-promoting agents or stimulants in patients with persistent sleepiness is uncertain. Existing data are limited, and small studies in selected patient groups (eg, multiple sclerosis, Parkinson disease, cancer) have had mixed results. (See <a class="local">'Evaluation and management'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Safety and driving</strong> – Regardless of the underlying cause, patients with EDS should be warned about the risks of drowsy driving and educated about prevention and risk modification. (See  <a class="medical medical_review" href="/z/d/html/101086.html" rel="external">"Drowsy driving: Risks, evaluation, and management", section on 'Prevention and countermeasures'</a>.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Valko PO, Bassetti CL, Bloch KE, et al. Validation of the fatigue severity scale in a Swiss cohort. Sleep 2008; 31:1601.</a></li><li><a class="nounderline abstract_t">Hossain JL, Ahmad P, Reinish LW, et al. Subjective fatigue and subjective sleepiness: two independent consequences of sleep disorders? J Sleep Res 2005; 14:245.</a></li><li><a class="nounderline abstract_t">Consensus Conference Panel, Watson NF, Badr MS, et al. Recommended Amount of Sleep for a Healthy Adult: A Joint Consensus Statement of the American Academy of Sleep Medicine and Sleep Research Society. J Clin Sleep Med 2015; 11:591.</a></li><li><a class="nounderline abstract_t">Sterr A, Herron K, Dijk DJ, Ellis J. Time to wake-up: sleep problems and daytime sleepiness in long-term stroke survivors. Brain Inj 2008; 22:575.</a></li><li><a class="nounderline abstract_t">Johnson KG, Johnson DC. Frequency of sleep apnea in stroke and TIA patients: a meta-analysis. J Clin Sleep Med 2010; 6:131.</a></li><li><a class="nounderline abstract_t">Bassetti CL, Milanova M, Gugger M. Sleep-disordered breathing and acute ischemic stroke: diagnosis, risk factors, treatment, evolution, and long-term clinical outcome. Stroke 2006; 37:967.</a></li><li><a class="nounderline abstract_t">Goldstein LB. Potential effects of common drugs on stroke recovery. Arch Neurol 1998; 55:454.</a></li><li><a class="nounderline abstract_t">Collen J, Orr N, Lettieri CJ, et al. Sleep disturbances among soldiers with combat-related traumatic brain injury. Chest 2012; 142:622.</a></li><li><a class="nounderline abstract_t">Masel BE, Scheibel RS, Kimbark T, Kuna ST. Excessive daytime sleepiness in adults with brain injuries. Arch Phys Med Rehabil 2001; 82:1526.</a></li><li><a class="nounderline abstract_t">Watson NF, Dikmen S, Machamer J, et al. Hypersomnia following traumatic brain injury. J Clin Sleep Med 2007; 3:363.</a></li><li><a class="nounderline abstract_t">Baumann CR, Werth E, Stocker R, et al. Sleep-wake disturbances 6 months after traumatic brain injury: a prospective study. Brain 2007; 130:1873.</a></li><li><a class="nounderline abstract_t">Braley TJ, Segal BM, Chervin RD. Hypnotic use and fatigue in multiple sclerosis. Sleep Med 2015; 16:131.</a></li><li><a class="nounderline abstract_t">Bosse-Henck A, Koch R, Wirtz H, Hinz A. Fatigue and Excessive Daytime Sleepiness in Sarcoidosis: Prevalence, Predictors, and Relationships between the Two Symptoms. Respiration 2017; 94:186.</a></li><li><a class="nounderline abstract_t">Grigg-Damberger M, Foldvary-Schaefer N. Bidirectional relationships of sleep and epilepsy in adults with epilepsy. Epilepsy Behav 2021; 116:107735.</a></li><li><a class="nounderline abstract_t">Klobucníková K, Carnická Z, Wagnerová H, Siarnik P. Is nocturnal epilepsy cause of disturbed quality of sleep and elevated daytime sleepiness? Neuro Endocrinol Lett 2014; 35:405.</a></li><li><a class="nounderline abstract_t">Jain SV, Glauser TA. Effects of epilepsy treatments on sleep architecture and daytime sleepiness: an evidence-based review of objective sleep metrics. Epilepsia 2014; 55:26.</a></li><li><a class="nounderline abstract_t">Cochen De Cock V, Bayard S, Jaussent I, et al. Daytime sleepiness in Parkinson's disease: a reappraisal. PLoS One 2014; 9:e107278.</a></li><li><a class="nounderline abstract_t">Amara AW, Chahine LM, Caspell-Garcia C, et al. Longitudinal assessment of excessive daytime sleepiness in early Parkinson's disease. J Neurol Neurosurg Psychiatry 2017; 88:653.</a></li><li><a class="nounderline abstract_t">Thannickal TC, Lai YY, Siegel JM. Hypocretin (orexin) cell loss in Parkinson's disease. Brain 2007; 130:1586.</a></li><li><a class="nounderline abstract_t">Moreno-López C, Santamaría J, Salamero M, et al. Excessive daytime sleepiness in multiple system atrophy (SLEEMSA study). Arch Neurol 2011; 68:223.</a></li><li><a class="nounderline abstract_t">Weisman D, McKeith I. Dementia with Lewy bodies. Semin Neurol 2007; 27:42.</a></li><li><a class="nounderline abstract_t">Park M, Hood MM, Shah RC, et al. Sleepiness, parkinsonian features and sustained attention in mild Alzheimer's disease. Age Ageing 2012; 41:765.</a></li><li><a class="nounderline abstract_t">Brusse E, Brusse-Keizer MG, Duivenvoorden HJ, van Swieten JC. Fatigue in spinocerebellar ataxia: patient self-assessment of an early and disabling symptom. Neurology 2011; 76:953.</a></li><li><a class="nounderline abstract_t">Pedroso JL, França MC Jr, Braga-Neto P, et al. Nonmotor and extracerebellar features in Machado-Joseph disease: a review. Mov Disord 2013; 28:1200.</a></li><li><a class="nounderline abstract_t">D'Abreu A, França M Jr, Conz L, et al. Sleep symptoms and their clinical correlates in Machado-Joseph disease. Acta Neurol Scand 2009; 119:277.</a></li><li><a class="nounderline abstract_t">Liguori C, Pierantozzi M, Spanetta M, et al. Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection. Brain Behav Immun 2020; 88:11.</a></li><li><a class="nounderline abstract_t">Merikanto I, Dauvilliers Y, Chung F, et al. Sleep symptoms are essential features of long-COVID - Comparing healthy controls with COVID-19 cases of different severity in the international COVID sleep study (ICOSS-II). J Sleep Res 2023; 32:e13754.</a></li><li><a class="nounderline abstract_t">Lundkvist GB, Kristensson K, Bentivoglio M. Why trypanosomes cause sleeping sickness. Physiology (Bethesda) 2004; 19:198.</a></li><li><a class="nounderline abstract_t">Rijo-Ferreira F, Carvalho T, Afonso C, et al. Sleeping sickness is a circadian disorder. Nat Commun 2018; 9:62.</a></li><li><a class="nounderline abstract_t">Han F, Lin L, Warby SC, et al. Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China. Ann Neurol 2011; 70:410.</a></li><li><a class="nounderline abstract_t">Sturkenboom MC. The narcolepsy-pandemic influenza story: can the truth ever be unraveled? Vaccine 2015; 33 Suppl 2:B6.</a></li><li><a class="nounderline abstract_t">Ahmed SS, Volkmuth W, Duca J, et al. Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2. Sci Transl Med 2015; 7:294ra105.</a></li><li><a class="nounderline abstract_t">Gaig C, Graus F, Compta Y, et al. Clinical manifestations of the anti-IgLON5 disease. Neurology 2017; 88:1736.</a></li><li><a class="nounderline abstract_t">Overeem S, Dalmau J, Bataller L, et al. Hypocretin-1 CSF levels in anti-Ma2 associated encephalitis. Neurology 2004; 62:138.</a></li><li><a class="nounderline abstract_t">Lam EM, Shepard PW, St Louis EK, et al. Restless legs syndrome and daytime sleepiness are prominent in myotonic dystrophy type 2. Neurology 2013; 81:157.</a></li><li><a class="nounderline abstract_t">Gibbs JW 3rd, Ciafaloni E, Radtke RA. Excessive daytime somnolence and increased rapid eye movement pressure in myotonic dystrophy. Sleep 2002; 25:662.</a></li><li><a class="nounderline abstract_t">Kassardjian CD, Murray BJ, Kokokyi S, et al. Effects of napping on neuromuscular fatigue in myasthenia gravis. Muscle Nerve 2013; 48:816.</a></li><li><a class="nounderline abstract_t">Liu S, Huang Y, Tai H, et al. Excessive daytime sleepiness in Chinese patients with sporadic amyotrophic lateral sclerosis and its association with cognitive and behavioural impairments. J Neurol Neurosurg Psychiatry 2018; 89:1038.</a></li><li><a class="nounderline abstract_t">Hoffmann HM, Malo-Juvera V, Statland JM. Self-reported reduced sleep quality and excessive daytime sleepiness in facioscapulohumeral muscular dystrophy. Muscle Nerve 2022; 66:487.</a></li><li><a class="nounderline abstract_t">Baets J, Duan X, Wu Y, et al. Defects of mutant DNMT1 are linked to a spectrum of neurological disorders. Brain 2015; 138:845.</a></li><li><a class="nounderline abstract_t">Bagai K, Song Y, Ling JF, et al. Sleep disturbances and diminished quality of life in postural tachycardia syndrome. J Clin Sleep Med 2011; 7:204.</a></li><li><a class="nounderline abstract_t">Stroe AF, Roth T, Jefferson C, et al. Comparative levels of excessive daytime sleepiness in common medical disorders. Sleep Med 2010; 11:890.</a></li><li><a class="nounderline abstract_t">Kim J, Cho SJ, Kim WJ, et al. Excessive daytime sleepiness is associated with an exacerbation of migraine: A population-based study. J Headache Pain 2016; 17:62.</a></li><li><a class="nounderline abstract_t">Güven B, Güven H, Çomoğlu SS. Migraine and Yawning. Headache 2018; 58:210.</a></li><li><a class="nounderline abstract_t">Gori S, Lucchesi C, Baldacci F, Bonuccelli U. Preferential occurrence of attacks during night sleep and/or upon awakening negatively affects migraine clinical presentation. Funct Neurol 2015; 30:119.</a></li><li><a class="nounderline abstract_t">Kristoffersen ES, Stavem K, Lundqvist C, Russell MB. Excessive daytime sleepiness in secondary chronic headache from the general population. J Headache Pain 2017; 18:85.</a></li><li><a class="nounderline abstract_t">Maas AP, Sinnema M, Didden R, et al. Sleep disturbances and behavioural problems in adults with Prader-Willi syndrome. J Intellect Disabil Res 2010; 54:906.</a></li><li><a class="nounderline abstract_t">Ghergan A, Coupaye M, Leu-Semenescu S, et al. Prevalence and Phenotype of Sleep Disorders in 60 Adults With Prader-Willi Syndrome. Sleep 2017; 40.</a></li><li><a class="nounderline abstract_t">Nevsimalova S, Vankova J, Stepanova I, et al. Hypocretin deficiency in Prader-Willi syndrome. Eur J Neurol 2005; 12:70.</a></li><li><a class="nounderline abstract_t">Vankova J, Stepanova I, Jech R, et al. Sleep disturbances and hypocretin deficiency in Niemann-Pick disease type C. Sleep 2003; 26:427.</a></li><li><a class="nounderline abstract_t">Shevell M, Ashwal S, Donley D, et al. Practice parameter: evaluation of the child with global developmental delay: report of the Quality Standards Subcommittee of the American Academy of Neurology and The Practice Committee of the Child Neurology Society. Neurology 2003; 60:367.</a></li><li><a class="nounderline abstract_t">Goldman SE, Malow BA, Newman KD, et al. Sleep patterns and daytime sleepiness in adolescents and young adults with Williams syndrome. J Intellect Disabil Res 2009; 53:182.</a></li><li><a class="nounderline abstract_t">Smith AC, Dykens E, Greenberg F. Sleep disturbance in Smith-Magenis syndrome (del 17 p11.2). Am J Med Genet 1998; 81:186.</a></li><li><a class="nounderline abstract_t">Downs J, Jacoby P, Saldaris J, et al. Negative impact of insomnia and daytime sleepiness on quality of life in individuals with the cyclin-dependent kinase-like 5 deficiency disorder. J Sleep Res 2022; 31:e13600.</a></li><li><a class="nounderline abstract_t">Wang D, Piper AJ, Yee BJ, et al. Hypercapnia is a key correlate of EEG activation and daytime sleepiness in hypercapnic sleep disordered breathing patients. J Clin Sleep Med 2014; 10:517.</a></li><li><a class="nounderline abstract_t">Kapsimalis F, Basta M, Varouchakis G, et al. Cytokines and pathological sleep. Sleep Med 2008; 9:603.</a></li><li><a class="nounderline abstract_t">Saper CB, Romanovsky AA, Scammell TE. Neural circuitry engaged by prostaglandins during the sickness syndrome. Nat Neurosci 2012; 15:1088.</a></li><li><a class="nounderline abstract_t">Westhovens R, Van der Elst K, Matthys A, et al. Sleep problems in patients with rheumatoid arthritis. J Rheumatol 2014; 41:31.</a></li><li><a class="nounderline abstract_t">Le Guen Y, Gagnadoux F, Hureaux J, et al. Sleep disturbances and impaired daytime functioning in outpatients with newly diagnosed lung cancer. Lung Cancer 2007; 58:139.</a></li><li><a class="nounderline abstract_t">Wolfe J, Orellana L, Ullrich C, et al. Symptoms and Distress in Children With Advanced Cancer: Prospective Patient-Reported Outcomes From the PediQUEST Study. J Clin Oncol 2015; 33:1928.</a></li><li><a class="nounderline abstract_t">Roscoe JA, Kaufman ME, Matteson-Rusby SE, et al. Cancer-related fatigue and sleep disorders. Oncologist 2007; 12 Suppl 1:35.</a></li><li><a class="nounderline abstract_t">Enderlin CA, Coleman EA, Cole C, et al. Sleep across chemotherapy treatment: a growing concern for women older than 50 with breast cancer. Oncol Nurs Forum 2010; 37:461.</a></li><li><a class="nounderline abstract_t">Jaumally BA, Das A, Cassell NC, et al. Excessive daytime sleepiness in cancer patients. Sleep Breath 2021; 25:1063.</a></li><li><a class="nounderline abstract_t">Kara O, Elibol T, Koc Okudur S, et al. Associations between anemia and insomnia or excessive daytime sleepiness in older adults. Acta Clin Belg 2023; 78:223.</a></li><li><a class="nounderline abstract_t">Allen RP, Barker PB, Wehrl FW, et al. MRI measurement of brain iron in patients with restless legs syndrome. Neurology 2001; 56:263.</a></li><li><a class="nounderline abstract_t">Sharma S, Efird JT, Knupp C, et al. Sleep disorders in adult sickle cell patients. J Clin Sleep Med 2015; 11:219.</a></li><li><a class="nounderline abstract_t">Newton JL, Reese JA, Watson SI, et al. Fatigue in adult patients with primary immune thrombocytopenia. Eur J Haematol 2011; 86:420.</a></li><li><a class="nounderline abstract_t">Newton JL, Gibson GJ, Tomlinson M, et al. Fatigue in primary biliary cirrhosis is associated with excessive daytime somnolence. Hepatology 2006; 44:91.</a></li><li><a class="nounderline abstract_t">Li W, Kadler BK, Brindley JH, et al. The contribution of daytime sleepiness to impaired quality of life in NAFLD in an ethnically diverse population. Sci Rep 2022; 12:5123.</a></li><li><a class="nounderline abstract_t">Hanly P. Sleep apnea and daytime sleepiness in end-stage renal disease. Semin Dial 2004; 17:109.</a></li><li><a class="nounderline abstract_t">Chen W, Xu Y, Li ZH, et al. Serum metabolic alterations in peritoneal dialysis patients with excessive daytime sleepiness. Ren Fail 2023; 45:2190815.</a></li><li><a class="nounderline abstract_t">Shinno H, Inami Y, Inagaki T, et al. Successful treatment with levothyroxine for idiopathic hypersomnia patients with subclinical hypothyroidism. Gen Hosp Psychiatry 2009; 31:190.</a></li><li><a class="nounderline abstract_t">van der Klaauw AA, Dekkers OM, Pereira AM, et al. Increased daytime somnolence despite normal sleep patterns in patients treated for nonfunctioning pituitary macroadenoma. J Clin Endocrinol Metab 2007; 92:3898.</a></li><li><a class="nounderline abstract_t">Inkster B, Riha RL, Van Look L, et al. Association between excessive daytime sleepiness and severe hypoglycemia in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes Care 2013; 36:4157.</a></li><li><a class="nounderline abstract_t">Nandalike K, Strauss T, Agarwal C, et al. Screening for sleep-disordered breathing and excessive daytime sleepiness in adolescent girls with polycystic ovarian syndrome. J Pediatr 2011; 159:591.</a></li><li><a class="nounderline abstract_t">Campos-Ordonez T, Gonzalez-Perez O. Cyclohexane, a Potential Drug of Abuse with Pernicious Effects on the Brain. Front Pharmacol 2015; 6:291.</a></li><li><a class="nounderline abstract_t">Viaene M, Vermeir G, Godderis L. Sleep disturbances and occupational exposure to solvents. Sleep Med Rev 2009; 13:235.</a></li><li><a class="nounderline abstract_t">Guda N, Partington S, Shaw MJ, et al. Unrecognized GERD symptoms are associated with excessive daytime sleepiness in patients undergoing sleep studies. Dig Dis Sci 2007; 52:2873.</a></li><li><a class="nounderline abstract_t">Ito T, Yamadera H, Ito R, et al. Effects of vitamin B12 on bright light on cognitive and sleep-wake rhythm in Alzheimer-type dementia. Psychiatry Clin Neurosci 2001; 55:281.</a></li><li><a class="nounderline abstract_t">Kerley CP, Hutchinson K, Bolger K, et al. Serum Vitamin D Is Significantly Inversely Associated with Disease Severity in Caucasian Adults with Obstructive Sleep Apnea Syndrome. Sleep 2016; 39:293.</a></li><li><a class="nounderline abstract_t">Signal TL, Paine SJ, Sweeney B, et al. Prevalence of abnormal sleep duration and excessive daytime sleepiness in pregnancy and the role of socio-demographic factors: comparing pregnant women with women in the general population. Sleep Med 2014; 15:1477.</a></li><li><a class="nounderline abstract_t">Bourjeily G, Raker C, Chalhoub M, Miller M. Excessive daytime sleepiness in late pregnancy may not always be normal: results from a cross-sectional study. Sleep Breath 2013; 17:735.</a></li><li><a class="nounderline abstract_t">Shukla G, Gupta A, Agarwal P, Poornima S. Behavioral effects and somnolence due to levetiracetam versus oxcarbazepine - a retrospective comparison study of North Indian patients with refractory epilepsy. Epilepsy Behav 2016; 64:216.</a></li><li><a class="nounderline abstract_t">Loebel AD, Siu CO, Cucchiaro JB, et al. Daytime sleepiness associated with lurasidone and quetiapine XR: results from a randomized double-blind, placebo-controlled trial in patients with schizophrenia. CNS Spectr 2014; 19:197.</a></li><li><a class="nounderline abstract_t">Rizo C, Deshpande A, Ing A, Seeman N. A rapid, Web-based method for obtaining patient views on effects and side-effects of antidepressants. J Affect Disord 2011; 130:290.</a></li><li><a class="nounderline abstract_t">Arnulf I, Leu-Semenescu S. Sleepiness in Parkinson's disease. Parkinsonism Relat Disord 2009; 15 Suppl 3:S101.</a></li><li><a class="nounderline abstract_t">Murphy PJ, Badia P, Myers BL, et al. Nonsteroidal anti-inflammatory drugs affect normal sleep patterns in humans. Physiol Behav 1994; 55:1063.</a></li><li><a class="nounderline abstract_t">Sutter R, Rüegg S, Tschudin-Sutter S. Seizures as adverse events of antibiotic drugs: A systematic review. Neurology 2015; 85:1332.</a></li><li><a class="nounderline abstract_t">Dzodzomenyo S, Stolfi A, Splaingard D, et al. Urine toxicology screen in multiple sleep latency test: the correlation of positive tetrahydrocannabinol, drug negative patients, and narcolepsy. J Clin Sleep Med 2015; 11:93.</a></li><li><a class="nounderline abstract_t">Zgierska A, Brown RT, Zuelsdorff M, et al. Sleep and daytime sleepiness problems among patients with chronic noncancerous pain receiving long-term opioid therapy: a cross-sectional study. J Opioid Manag 2007; 3:317.</a></li><li><a class="nounderline abstract_t">Maski K, Trotti LM, Kotagal S, et al. Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med 2021; 17:1881.</a></li><li><a class="nounderline abstract_t">Maski K, Trotti LM, Kotagal S, et al. Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment. J Clin Sleep Med 2021; 17:1895.</a></li><li><a class="nounderline abstract_t">Pépin JL, Georgiev O, Tiholov R, et al. Pitolisant for Residual Excessive Daytime Sleepiness in OSA Patients Adhering to CPAP: A Randomized Trial. Chest 2021; 159:1598.</a></li><li><a class="nounderline abstract_t">Subedi R, Singh R, Thakur RK, et al. Efficacy and safety of solriamfetol for excessive daytime sleepiness in narcolepsy and obstructive sleep apnea: a systematic review and meta-analysis of clinical trials. Sleep Med 2020; 75:510.</a></li></ol></div><div id="topicVersionRevision">Topic 97865 Version 13.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19014080" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Validation of the fatigue severity scale in a Swiss cohort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16120099" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Subjective fatigue and subjective sleepiness: two independent consequences of sleep disorders?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25979105" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Recommended Amount of Sleep for a Healthy Adult: A Joint Consensus Statement of the American Academy of Sleep Medicine and Sleep Research Society.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18568710" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Time to wake-up: sleep problems and daytime sleepiness in long-term stroke survivors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20411688" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Frequency of sleep apnea in stroke and TIA patients: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16543515" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Sleep-disordered breathing and acute ischemic stroke: diagnosis, risk factors, treatment, evolution, and long-term clinical outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9561971" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Potential effects of common drugs on stroke recovery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22459784" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Sleep disturbances among soldiers with combat-related traumatic brain injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11689971" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Excessive daytime sleepiness in adults with brain injuries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17694724" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Hypersomnia following traumatic brain injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17584779" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Sleep-wake disturbances 6 months after traumatic brain injury: a prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25454981" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Hypnotic use and fatigue in multiple sclerosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28609770" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Fatigue and Excessive Daytime Sleepiness in Sarcoidosis: Prevalence, Predictors, and Relationships between the Two Symptoms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33561767" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Bidirectional relationships of sleep and epilepsy in adults with epilepsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25275263" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Is nocturnal epilepsy cause of disturbed quality of sleep and elevated daytime sleepiness?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24299283" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Effects of epilepsy treatments on sleep architecture and daytime sleepiness: an evidence-based review of objective sleep metrics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25198548" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Daytime sleepiness in Parkinson's disease: a reappraisal.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28554959" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Longitudinal assessment of excessive daytime sleepiness in early Parkinson's disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17491094" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Hypocretin (orexin) cell loss in Parkinson's disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21320989" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Excessive daytime sleepiness in multiple system atrophy (SLEEMSA study).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17226740" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Dementia with Lewy bodies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22743151" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Sleepiness, parkinsonian features and sustained attention in mild Alzheimer's disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21403106" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Fatigue in spinocerebellar ataxia: patient self-assessment of an early and disabling symptom.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23775899" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Nonmotor and extracerebellar features in Machado-Joseph disease: a review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18771522" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Sleep symptoms and their clinical correlates in Machado-Joseph disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32416289" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36208038" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Sleep symptoms are essential features of long-COVID - Comparing healthy controls with COVID-19 cases of different severity in the international COVID sleep study (ICOSS-II).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15304634" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Why trypanosomes cause sleeping sickness.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29302035" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Sleeping sickness is a circadian disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21866560" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26022571" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : The narcolepsy-pandemic influenza story: can the truth ever be unraveled?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26136476" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28381508" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Clinical manifestations of the anti-IgLON5 disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14718718" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Hypocretin-1 CSF levels in anti-Ma2 associated encephalitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23749798" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Restless legs syndrome and daytime sleepiness are prominent in myotonic dystrophy type 2.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12224846" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Excessive daytime somnolence and increased rapid eye movement pressure in myotonic dystrophy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23836427" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Effects of napping on neuromuscular fatigue in myasthenia gravis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30045943" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Excessive daytime sleepiness in Chinese patients with sporadic amyotrophic lateral sclerosis and its association with cognitive and behavioural impairments.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35893768" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Self-reported reduced sleep quality and excessive daytime sleepiness in facioscapulohumeral muscular dystrophy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25678562" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Defects of mutant DNMT1 are linked to a spectrum of neurological disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21509337" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Sleep disturbances and diminished quality of life in postural tachycardia syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20817600" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Comparative levels of excessive daytime sleepiness in common medical disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27363413" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Excessive daytime sleepiness is associated with an exacerbation of migraine: A population-based study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28960327" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Migraine and Yawning.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26415784" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Preferential occurrence of attacks during night sleep and/or upon awakening negatively affects migraine clinical presentation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28815442" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Excessive daytime sleepiness in secondary chronic headache from the general population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20636465" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Sleep disturbances and behavioural problems in adults with Prader-Willi syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29294134" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Prevalence and Phenotype of Sleep Disorders in 60 Adults With Prader-Willi Syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15613151" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Hypocretin deficiency in Prader-Willi syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12841368" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Sleep disturbances and hypocretin deficiency in Niemann-Pick disease type C.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12578916" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Practice parameter: evaluation of the child with global developmental delay: report of the Quality Standards Subcommittee of the American Academy of Neurology and The Practice Committee of the Child Neurology Society.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19067782" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Sleep patterns and daytime sleepiness in adolescents and young adults with Williams syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9613860" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Sleep disturbance in Smith-Magenis syndrome (del 17 p11.2).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35415902" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Negative impact of insomnia and daytime sleepiness on quality of life in individuals with the cyclin-dependent kinase-like 5 deficiency disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24910553" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Hypercapnia is a key correlate of EEG activation and daytime sleepiness in hypercapnic sleep disordered breathing patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18024171" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Cytokines and pathological sleep.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22837039" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Neural circuitry engaged by prostaglandins during the sickness syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24293569" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Sleep problems in patients with rheumatoid arthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17614157" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Sleep disturbances and impaired daytime functioning in outpatients with newly diagnosed lung cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25918277" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Symptoms and Distress in Children With Advanced Cancer: Prospective Patient-Reported Outcomes From the PediQUEST Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17573454" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Cancer-related fatigue and sleep disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20591805" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Sleep across chemotherapy treatment: a growing concern for women older than 50 with breast cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32939599" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Excessive daytime sleepiness in cancer patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36036443" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Associations between anemia and insomnia or excessive daytime sleepiness in older adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11160969" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : MRI measurement of brain iron in patients with restless legs syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25515282" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Sleep disorders in adult sickle cell patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21323737" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Fatigue in adult patients with primary immune thrombocytopenia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16800007" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Fatigue in primary biliary cirrhosis is associated with excessive daytime somnolence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35332193" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : The contribution of daytime sleepiness to impaired quality of life in NAFLD in an ethnically diverse population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15043611" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Sleep apnea and daytime sleepiness in end-stage renal disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37051665" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Serum metabolic alterations in peritoneal dialysis patients with excessive daytime sleepiness.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19269544" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Successful treatment with levothyroxine for idiopathic hypersomnia patients with subclinical hypothyroidism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17666479" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Increased daytime somnolence despite normal sleep patterns in patients treated for nonfunctioning pituitary macroadenoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24089545" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Association between excessive daytime sleepiness and severe hypoglycemia in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21645911" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Screening for sleep-disordered breathing and excessive daytime sleepiness in adolescent girls with polycystic ovarian syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26779017" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Cyclohexane, a Potential Drug of Abuse with Pernicious Effects on the Brain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19201227" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Sleep disturbances and occupational exposure to solvents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17406821" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Unrecognized GERD symptoms are associated with excessive daytime sleepiness in patients undergoing sleep studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11422876" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Effects of vitamin B12 on bright light on cognitive and sleep-wake rhythm in Alzheimer-type dementia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26414899" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Serum Vitamin D Is Significantly Inversely Associated with Disease Severity in Caucasian Adults with Obstructive Sleep Apnea Syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25311831" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Prevalence of abnormal sleep duration and excessive daytime sleepiness in pregnancy and the role of socio-demographic factors: comparing pregnant women with women in the general population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22872283" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Excessive daytime sleepiness in late pregnancy may not always be normal: results from a cross-sectional study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27756024" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Behavioral effects and somnolence due to levetiracetam versus oxcarbazepine - a retrospective comparison study of North Indian patients with refractory epilepsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24330860" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Daytime sleepiness associated with lurasidone and quetiapine XR: results from a randomized double-blind, placebo-controlled trial in patients with schizophrenia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20705344" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : A rapid, Web-based method for obtaining patient views on effects and side-effects of antidepressants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20082966" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Sleepiness in Parkinson's disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8047572" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Nonsteroidal anti-inflammatory drugs affect normal sleep patterns in humans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26400582" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Seizures as adverse events of antibiotic drugs: A systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25348245" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Urine toxicology screen in multiple sleep latency test: the correlation of positive tetrahydrocannabinol, drug negative patients, and narcolepsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18290583" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Sleep and daytime sleepiness problems among patients with chronic noncancerous pain receiving long-term opioid therapy: a cross-sectional study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34743789" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine clinical practice guideline.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34743790" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33121980" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Pitolisant for Residual Excessive Daytime Sleepiness in OSA Patients Adhering to CPAP: A Randomized Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33032062" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Efficacy and safety of solriamfetol for excessive daytime sleepiness in narcolepsy and obstructive sleep apnea: a systematic review and meta-analysis of clinical trials.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
